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ABSTRACT
Objectives: The incidence of gestational diabetes varies depending on a country and it is extremely difficult to analyse. 
The aim of the study was to assess the incidence of gestational diabetes in Polish population. 
Material and methods: Based on the data from the National Health Fund (NHF) the authors analysed reports regarding 
deliveries performed and then, determined the rates of gestational diabetes/hyperglycaemia during pregnancy and 
pregestational diabetes in Poland in the years 2010–2012. 
Results and conclusions: In Poland, the incidence of gestational diabetes was estimated to be 4.665% in 2010, 6.918% in 
2011 and 7.489% in 2012. The incidence of pregestational diabetes was 1.067% in 2010, 1.116% in 2011 and 0.932% in 2012.
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INTRODUCTION
The presence of gestational diabetes or hyperglycaemia 
during pregnancy depends on many risk factors, similarly 
like type 2 diabetes mellitus. 
After delivery, the blood glucose levels normalise in the 
majority of women. Criteria used to make a diagnosis of 
gestational diabetes were defined and described by Wilson 
and Jungner in 1968 [1].
The incidence of gestational diabetes varies depending 
on a country. The following factors affect development of 
hyperglycaemia during pregnancy: age, history of children 
with birth weight above 4000 g, newborns with congenital 
defects, intrauterine deaths, arterial hypertension, being 
overweight or obese, familial history or type 2 diabetes 
mellitus, diagnosis of gestational diabetes during previous 
pregnancies and polycystic ovarian syndrome [2].
Gestational diabetes or hyperglycaemia during preg-
nancy are currently defined as any event of impaired glucose 
tolerance that develops during or after delivery [3]. It is dif-
ficult to determine the incidence of gestational diabetes in 
various populations for numerous reasons: firstly, screening 
tests in various countries are scheduled differently, secondly, 
the criteria to diagnose gestational diabetes vary depending 
on a country, and thirdly, the incidence of type 2 diabetes 
is currently greater in a younger population compared to 
the past, and finally, populations are different and medical 
care also varies depending on a country.
In the period prior to pregnancy some women used to 
have unknown hyperglycaemia or diabetes.
All these factors make it extremely difficult to objectively 
assess the incidence of gestational diabetes and hypergly-
caemia during pregnancy [2].
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Some authors agree that gestational diabetes or hy-
perglycaemia during pregnancy only means detection of 
unknown diabetes mellitus or prediabetes that was revealed 
during pregnancy. According to such authors the incidence 
of gestational diabetes is similar to the incidence of diabetes 
in women at the similar age but who are not pregnant [4].
Women with a history of gestational diabetes have to 
be monitored for known diabetes in their later period of life. 
According to many authors a history of gestational diabetes 
is a risk factor of type 2 diabetes mellitus [5, 6]. 
The incidence of gestational diabetes varies depending 
on a country and ranges between 3% and 6% [6].
In the United States of America the incidence of gesta-
tional diabetes is estimated to be between 1% and 14% [7].
OBJECTIVES
The aim of the work was to determine the incidence of 
pregestational and gestational diabetes mellitus/hypergly-
caemia during pregnancy in Poland in the years 2010–2012 
based on the data from the National Health Fund.
MATERIAL AND METHODS
Health services in Poland are financed by the National 
Health Fund (NHF) based on the act [8] and regulations of 
the Minister of Health that result from this act [9, 10]. In Po-
land services are provided to patients as outpatient and in-
patient health care. Ordinances of the NHF President present 
methods to organise and finance services in detail [11, 12]. 
In order to perform a retrospective analysis and to ob-
tain data from report databases for statistical calculations 
based on the patient’s unique identifiers ([Powszechny 
Elektroniczny System Ewidencji Ludności, PESEL] common 
electronic system for personal identification [13]) cases, 
associated with a given PESEL number, when the following 
medical procedures were performed, were selected from 
public payer’s databases (JGP groups [similar to English HRG 
groups]): N01 — delivery; N02 — multiple or premature 
delivery; N03 — gestational or puerperial pathology 5 days; 
N09 — severe gestational pathology with delivery — diag-
nostic tests; N11 — mild gestational pathology with delivery 
— diagnostic tests; N13 — severe gestational pathology 
ended with delivery. The analysis time was determined as 
the period between 1.01.2010 and 31.12.2012. In total, in 
2010 the NHF received reports on 388 506 deliveries, in 
2011 — 370.731 deliveries, and in 2012 375 691 deliveries.
The data presented above were correlated with reported 
data on the coexisting diseases in pregnant women in order 
to detect diagnoses of diabetes mellitus: E 10.X — insu-
lin-dependent diabetes mellitus; E 11.X — non-insulin-de-
pendent diabetes mellitus; E 12.X — malnutrition-related 
diabetes mellitus; E 13.X — other unspecified forms of dia-
betes mellitus; E 14.X — unspecified diabetes mellitus or 
a patient filled a prescription for antidiabetic agents based 
on the ATC classification: A 10.X (insulins), A 10 B.X (oral 
anti-diabetic agents) and specialist diagnostic tests to moni-
tor blood glucose levels. 
Based on this database the study cohort was strati-
fied and the following groups were calculated: how many 
women in 2010, 2011 and 2012 had diabetes mellitus diag-
nosed prior to delivery, and how many women each year 
had diabetes mellitus diagnosed 365 days after delivery.
SAS, SQL and Statistica tools with the T-Student test 
were used for analyses.
In total, in 2010 there were (according to the NHF) 
388506 deliveries, in 2011 — 370 731 deliveries and in 
2012 — 375 691 deliveries.
In the NHF database in the period between 01.01 and 
31.12.2010, between 01.01 and 31.12.2011 and between 
01.01 and 31.12.2012 reports associated with diabetes mel-
litus with the main diagnosis of “diabetes mellitus” with the 
following determinants were identified: E 10.X — insulin-de-
pendent diabetes mellitus;
E 11.X — non-insulin-dependent diabetes mellitus; 
E 12.X — malnutrition-related diabetes mellitus; E 13.X 
— other unspecified forms of diabetes mellitus; E 14.X — un-
specified diabetes mellitus or in this period a patient had 
a prescription for any medicinal products from the group 
A 10.X (insulins), A 10 B.X (oral anti-diabetic agents) and 
specialist diagnostic tests. 
The following calculations were made: how many wo- 
men in each year: 2010, 2011 and 2012 had diabetes mellitus 
diagnosed prior to delivery, and how many women each 
year had diabetes mellitus diagnosed 365 days after delivery.
RESULTS
Table 1 lists the number of deliveries in Poland taking 
into account women with diabetes in the period 2010–2012, 
based on the NHF data.
In 2010 the number of deliveries in women with 
known diabetes was 22 270, in 2011 — 29 788, and in 
2012 — 31 638 deliveries.
It was not possible to determine when in women men-
tioned above diabetes was diagnosed: several years earlier 
or last year prior to delivery. This cohort also includes women 
with pregestational diabetes and with gestational diabe-
tes/hyperglycaemia during pregnancy.
365 days after delivery diabetes was observed in 
4 148 women who gave birth in 2010, in 4 139 women 
who gave birth in 2011 and in 3 502 women who gave 
birth in 2012.
This cohort includes women with pregestational dia-
betes and also those with diabetes that developed during 
pregnancy. The number of women who were not diagnosed 
with diabetes 365 days after delivery was 18 112 in 2010, 
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25 649 in 2011 and 28 136 in 2012 — these cohorts regard 
the number of women with gestational diabetes/hypergly-
caemia during pregnancy.
In the NHF records there were no data on services re-
garding treatment of diabetes and reports had no informa-
tion on the use of insulin, oral antidiabetic agents and strip 
tests to determine glucose levels in 2010 in 366 236 women, 
in 2011 in 340 943 women and in 2012 in 344 053 women, 
respectively. In total, according to the NHF data there were 
reports of 388 506 deliveries in 2010, 370 731 deliveries in 
2011 and 375 691 deliveries in 2012, respectively.
Table 2 presents the rate of gestational diabetes/hyper-
glycaemia during pregnancy in all women who gave birth in 
a given year according to the NHF data in the years 2010–2012.
Among women who gave birth in 2010 gestational dia-
betes or hyperglycaemia during pregnancy was diagnosed 
in 4.665%, in 2011 in 6.918% and in 2012 in 7.489%.
Table 3 presents the rates of pregestational diabetes in 
all women who gave birth in a given year according to the 
NHF data in the years 2010–2012 in Poland.
The rate of women with pregestational diabetes among 
all who gave birth in a given year was 1.067% in 2010, 
1.116% in 2011 and 0.932 in 2012.
DISCUSSION
As there are various methods for screening tests and 
various diagnostic criteria in various populations it is difficult 
to assess the incidence and to compare gestational diabetes 
or hyperglycaemia during pregnancy. There are numerous 
risk factors that may be identified in various ethnic groups. In 
the literature there have been for many years great con-
troversies regarding criteria of diabetes and the diagnosis 
itself [14]. According to some authors gestational diabetes 
means hyperglycaemia during pregnancy. 
Diabetes mellitus diagnosed during pregnancy included 
cases of pregestational diabetes and gestational diabetes. 
According to the recommendations of the Polish Dia-
betes Association in the period of our observations, namely 
in the years 2010–2012 gestational diabetes was diagnosed 
based on the results of the test with a 75 g glucose loading 
dose when the fasting glucose levels were > 100 mg/dL, and 
at 120 minutes they were ≥ 140 mg/dL [15].
Currently, in Poland and in the United States of America 
(USA) gestational diabetes is diagnosed based on the test 
with a 75 g glucose loading dose using one of these criteria: 
fasting levels 92–125 mg/dL, at 60 minutes ≥ 180 mg/dL and 
at 120 minutes 153–199 mg/dL [16, 17].
During pregnancy all pregnant women should have 
diagnostic tests for carbohydrate metabolism disturbances 
performed, namely fasting blood glucose levels should be 
determined at the first visit at OB/GYN. In women in a high 
risk group a diagnostic test should be performed — load 
with 75 g glucose. Even when the result is normal, a diagnos-
tic test with load with 75 g glucose should be performed in 
all pregnant women between week 24 and 28 of pregnancy.
During pregnancy hyperglycaemia is also observed 
as gestational diabetes mellitus, namely fasting glycae-
mia ≥ 126 mg/dL or glycaemia at 2 hours after load with 
75 g glucose is ≥ 200 mg/dL.
The incidence of diabetes among women aged 20–39 
years was determined to be <1% in Tanzania, 1–3% in China, 
7% in the Aboriginal population in Australia, and 14–22% 
in the people of Nauru [18].
The incidence of prediabetes was estimated to be below 
3% in women in China, above 10% in some subpopulations 
Table 1. Absolute values of the number of deliveries in Poland, taking into account presence of diabetes mellitus known prior to delivery and 
within 365 days after delivery in the years 2010–2012, based on the NHF data
The test groups  Year 2010 Year 2011  Year 2012  
Number of all deliveries 388 506 370 731 375 691
Number of deliveries with no known diabetes 366 236 340 943 344 053
 Number of deliveries in women with known diabetes before birth 22 270 29 788 31 638
Number of deliveries in women with diabetes 365 days after delivery 4 148 4 139 3 502
Number of deliveries in women who were observed gestational diabetes  
or hyperglycemia during pregnancy 18 122 25 649 28 136
Table 2. The rate of gestational diabetes/hyperglycaemia during 
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of Afroamerican women, and above 30% in women from 
the Pima Indians [18].
King presented the incidence of gestational diabetes in 
various populations in the world. So, the mean was 4% in 
the USA, approximately 14.3% in a group of Indians, 6% in 
Mexico, 2.3% in Italy and 3.1% in Japan [7]. King concludes 
that the incidence of gestational diabetes is similar to that 
of type 2 diabetes mellitus [7].
According to our observations in Poland the incidence 
of hyperglycaemia only during pregnancy/gestational dia-
betes ranged between 4.665% in 2010 to 7.489% in 2012.
Irrespective of this, in our studies diabetes mellitus that 
was observed 365 after delivery ranged between 1.067% in 
2010 to 0.932% in 2012.
It should be assumed with some limitations that the 
rate of hyperglycaemia observed during pregnancy that 
disappeared 365 days after delivery indicates women with 
gestational diabetes. Moreover, it cannot be excluded that 
women who were diagnosed with diabetes 365 days after 
delivery included women with pregestational diabetes that 
developed during pregnancy. 
Observational methods we used were not appropriate 
to detect women who developed type 1 and 2 diabetes 
mellitus during pregnancy and this constitutes a limitation 
to diagnose gestational diabetes or hyperglycaemia only 
during pregnancy. In total, in 2010 gestational diabetes was 
observed in Poland in 5.732% of all women who gave birth 
in this year. In 2011 it was 8.034% of all deliveries, and in 
2012 — 8.425%. In Poland in 2012 the rate of women with 
newly diagnosed diabetes was as follows: 
1. In the age group of 21–30 years — 8.451%;
2. In the age group of 31–40 years — 9.392%;
3. In the age group of 41–50 years — 7.584% [19].
In our studies the incidence of new cases of diabetes in 
the population of women at the age of 21 to 50 years was 
similar to the incidence of gestational diabetes.
A diagnosis of gestational diabetes should be carefully 
treated as an early phase of carbohydrate metabolism dis-
turbances that appears during pregnancy due to changed 
metabolic conditions in women with risk factors of type 
2 diabetes mellitus and in the future it may be associated 
with early development of type 2 diabetes mellitus. It has 
to be added that some women with hyperglycaemia during 
pregnancy also showed abnormal glucose tolerance during 
pregnancy but no diagnostic tests were performed.
Type 2 diabetes mellitus is estimated to develop in 
17–63% of women with a history of gestational diabetes 
within 5 to 16 years after delivery. On the other hand, the 
incidence of type 1 diabetes mellitus in women with a his-
tory of gestational diabetes is estimated to be between 
1.7% and 6.8% [20, 21].
According to some authors type 2 diabetes mellitus 
is observed seven times more frequently in women with 
a history of gestational diabetes compared to those without 
such a history [22].
Gestational diabetes is associated with a risk of foetal 
macrosomia, neonatal hypoglycaemia after delivery and 
a higher risk of delivery via Caesarean section [23, 24]. The 
real incidence of gestational diabetes is not easy to deter-
mine. 
In an American multicentre study (PRAMS) Desisto et al. 
presented the incidence of gestational diabetes among 
1353810 deliveries in a group of women from 15 states and 
New York City in 2010 [25].
23 479 women with gestational diabetes were analysed 
with a special questionnaire. Gestational diabetes was ob-
served in 9.2% of women, but at the same time the presence 
of gestational diabetes was analysed in the same cohort of 
women based on birth certificates — gestational diabetes 
was observed in 4.6% of women [25]. The incidence of gesta-
tional diabetes in Caucasian women was 6.8%, 16.3% in the 
Asian population and 12.1% in the Latino population [25].
According to Nerup type 1 diabetes mellitus is a dif-
ficult problem for geneticists and gestational diabetes is 
an extremely complex problem that is not fully solvable for 
epidemiologists [2].
CONCLUSIONS
In Poland, the incidence of gestational diabetes/hyper-
glycaemia during pregnancy was 4.665% in 2010, 6.918% 
in 2011 and 7.489% in 2012 with regard to all women who 
gave birth in a given year.
In Poland, the incidence of pregestational diabetes was 
1.067% in 2010, 1.116% in 2011 and 0.932% in 2012 with 
regard to all women who gave birth in a given year. 
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